CorMedix Inc. (CRMD)

Latest Insider Confidence Score

2026Q1

49.6
Bearish

Company insider confidence (by quarter)

2010Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Milby Randy CEO 1,050,000 Aug 10, 2016
Gelbfish Gary A. Director 879,000 Jan 11, 2019
Pharmabio Development Inc 10% Owner 778,563 Apr 13, 2012
Baluch Khoso CEO 661,135 Jan 13, 2021
Duffy Matthew Director 553,400 Jun 6, 2016

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 4, 2026 Feb 6, 2026 Zelnick Kaufman Beth Chief Legal Officer Neutral 90.0 +36,006 15.45% ✗ -
Feb 4, 2026 Feb 6, 2026 Hurlburt Elizabeth COO Neutral 90.0 +36,006 14.85% ✗ -
Feb 4, 2026 Feb 6, 2026 Todisco Joseph CEO Neutral 90.0 +77,156 11.06% ✗ -
Jan 23, 2026 Jan 27, 2026 Blum Susan CFO Sell 95.0 +63,053 90.48% ✗ $71K
Jan 23, 2026 Jan 27, 2026 Zelnick Kaufman Beth Chief Legal Officer Sell 95.0 +64,017 37.86% ✗ $64K
Jan 23, 2026 Jan 27, 2026 Hurlburt Elizabeth COO Sell 95.0 +82,232 51.30% ✗ $78.4K
Jan 23, 2026 Jan 27, 2026 Todisco Joseph CEO Sell 95.0 +198,594 39.80% ✗ $198.5K
Jan 26, 2026 Jan 27, 2026 Kaplan Myron Director Neutral 90.0 +30,453 13.18% ✗ -
Jan 26, 2026 Jan 27, 2026 Dillione Janet Director Neutral 90.0 +30,453 79.15% ✗ -
Jan 26, 2026 Jan 27, 2026 Lefkowitz Steven W Director Neutral 90.0 +30,453 23.86% ✗ -
Jan 26, 2026 Jan 27, 2026 DUNTON ALAN W Director Neutral 90.0 +30,453 75.66% ✗ -
Jan 26, 2026 Jan 27, 2026 Duncan Gregory Scott Director Neutral 90.0 +30,453 79.44% ✗ -
Jan 26, 2026 Jan 27, 2026 Stewart Robert A Director Neutral 90.0 +30,453 84.59% ✗ -
Jan 21, 2026 Jan 22, 2026 Dillione Janet Director Sell 22.5 -10,000 -20.63% ✗ $68.8K
Jan 12, 2026 Jan 20, 2026 Hurlburt Elizabeth COO Sell 26.3 -5,794 -3.49% ✗ $41.4K
Jan 12, 2026 Jan 20, 2026 Todisco Joseph CEO Sell 20.0 -40,082 -3.89% ✗ $278.2K
Jan 8, 2026 Jan 15, 2026 Seckler Michael David Chief Commercial Officer Neutral 90.0 +133,156 100.00% ✗ -
Jan 15, 2026 Seckler Michael David Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Jan 14, 2026 Lefkowitz Steven W Director Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Hurlburt Elizabeth COO Sell 22.5 -10,895 -6.16% ✗ $132.5K
Jan 2, 2026 Jan 6, 2026 Zelnick Kaufman Beth Chief Legal Officer Sell 22.5 -11,333 -6.28% ✗ $137.8K
Dec 30, 2025 Jan 2, 2026 DUNTON ALAN W Director Sell 20.0 -20,000 -33.20% ✗ $260K
Dec 18, 2025 Dec 19, 2025 Todisco Joseph CEO Sell 20.0 -30,000 -5.56% ✗ $360K
Dec 9, 2025 Dec 11, 2025 Dillione Janet Director Sell 20.0 -34,000 -41.23% ✗ $408K
Dec 9, 2025 Dec 10, 2025 Lefkowitz Steven W Director Sell 20.0 -40,000 -26.20% ✗ $475.2K
Dec 2, 2025 Dec 4, 2025 Dillione Janet Director Sell 20.0 -46,657 -49.05% ✗ $466.6K
Nov 24, 2025 Nov 26, 2025 Dillione Janet Director Sell 20.0 -26,343 -35.21% ✗ $261.6K
Nov 14, 2025 Nov 18, 2025 Dillione Janet Director Sell 20.0 -30,000 -38.23% ✗ $342.6K
Oct 23, 2025 Oct 27, 2025 Kaplan Myron Director Buy 97.5 +25,000 12.13% ✗ $275.5K
Sep 16, 2025 Sep 18, 2025 Duncan Gregory Scott Director Neutral 52.5 - 0.00% ✗ -
Sep 12, 2025 Sep 16, 2025 DUNTON ALAN W Director Sell 22.5 -10,000 -19.90% ✗ $131.3K
Sep 12, 2025 Sep 12, 2025 Todisco Joseph CEO Sell 20.0 -50,000 -8.94% ✗ $650K
May 10, 2025 Sep 12, 2025 Todisco Joseph CEO Sell 22.5 -21,225 -4.00% ✗ $247.5K
Sep 9, 2025 Sep 11, 2025 Zelnick Kaufman Beth Chief Legal Officer Sell 20.0 -50,000 -21.70% ✗ $670.3K
Sep 9, 2025 Sep 11, 2025 Hurlburt Elizabeth COO Sell 20.0 -53,997 -13.24% ✗ $711.8K
Aug 29, 2025 Sep 8, 2025 Hurlburt Elizabeth COO Sell 42.5 -8,424 -4.54% ✗ $124.9K
Aug 29, 2025 Sep 8, 2025 Zelnick Kaufman Beth Chief Legal Officer Sell 42.5 -8,880 -4.69% ✗ $131.7K
Aug 29, 2025 Sep 3, 2025 Hurlburt Elizabeth COO Neutral 90.0 +69,686 60.22% ✗ -
Aug 29, 2025 Sep 3, 2025 Zelnick Kaufman Beth Chief Legal Officer Neutral 90.0 +69,686 58.26% ✗ -
Aug 29, 2025 Sep 3, 2025 Blum Susan CFO Neutral 90.0 +69,686 100.00% ✗ -
Sep 3, 2025 Blum Susan CFO Neutral 52.5 - 0.00% ✗ -
Apr 2, 2025 Apr 3, 2025 Lefkowitz Steven W Director Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 2, 2025 Todisco Joseph CEO Neutral 52.5 - 0.00% ✗ -
Jan 17, 2025 Jan 22, 2025 Todisco Joseph CEO Sell 97.5 +163,523 53.09% ✗ $291.8K
Jan 17, 2025 Jan 22, 2025 DUNTON ALAN W Director Neutral 90.0 +25,000 163.93% ✗ -
Jan 17, 2025 Jan 22, 2025 Stewart Robert A Director Neutral 90.0 +25,000 227.27% ✗ -
Jan 17, 2025 Jan 22, 2025 Dillione Janet Director Neutral 90.0 +25,000 46.75% ✗ -
Jan 17, 2025 Jan 22, 2025 Kaplan Myron Director Neutral 90.0 +25,000 13.81% ✗ -
Jan 17, 2025 Jan 22, 2025 Lefkowitz Steven W Director Neutral 90.0 +25,000 23.22% ✗ -
Jan 17, 2025 Jan 22, 2025 Duncan Gregory Scott Director Neutral 90.0 +25,000 100.00% ✗ -
Jan 10, 2025 Jan 14, 2025 David Matthew T CFO Sell 22.5 -6,515 -6.40% ✗ $72.9K
Jan 10, 2025 Jan 14, 2025 Todisco Joseph CEO Sell 22.5 -17,829 -5.47% ✗ $199.5K
Jan 10, 2025 Jan 14, 2025 Mistry Erin EVP, Chief Commercial Officer Sell 22.5 -5,689 -5.33% ✗ $63.7K
Jan 10, 2025 Jan 14, 2025 Hurlburt Elizabeth EVP Sell 22.5 -5,790 -4.76% ✗ $64.8K
Jan 2, 2025 Jan 6, 2025 Mistry Erin EVP, Chief Commercial Officer Sell 95.0 +54,670 105.11% ✗ $64.4K
Jan 2, 2025 Jan 6, 2025 Hurlburt Elizabeth EVP Sell 95.0 +76,122 167.68% ✗ $93.5K
Jan 2, 2025 Jan 6, 2025 David Matthew T CFO Sell 95.0 +53,852 112.35% ✗ $71.1K
Jan 2, 2025 Jan 6, 2025 Zelnick Kaufman Beth Chief Legal Officer Sell 95.0 +75,656 172.12% ✗ $97.4K
Dec 12, 2024 Dec 18, 2024 Zelnick Kaufman Beth Chief Legal Officer Sell 22.5 -6,044 -12.09% ✗ $53K
Dec 12, 2024 Dec 16, 2024 Zelnick Kaufman Beth Chief Legal Officer Sell 22.5 -6,044 -9.67% ✗ $53K
Oct 31, 2024 Dec 13, 2024 Mistry Erin EVP, Chief Commercial Officer Buy 83.8 +1,500 2.97% ✗ $15K
Nov 14, 2024 Nov 18, 2024 Hurlburt Elizabeth EVP Sell 17.5 -140,027 -75.52% ✗ $1.6M
May 10, 2024 May 13, 2024 Todisco Joseph CEO Sell 22.5 -26,982 -7.65% ✗ $139.5K
Mar 5, 2024 Mar 20, 2024 Lefkowitz Steven W Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 20, 2024 Stewart Robert A Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 20, 2024 Kaplan Myron Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 20, 2024 Dillione Janet Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 20, 2024 DUNTON ALAN W Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 20, 2024 Duncan Gregory Scott Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 14, 2024 Todisco Joseph CEO Buy 87.5 +13,561 4.00% ✗ $50.7K
Jan 18, 2024 Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. Neutral 52.5 - 0.00% ✗ -
Jan 12, 2024 Jan 17, 2024 Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. Sell 91.3 +45,397 567.46% ✗ $16K
Jan 12, 2024 Jan 17, 2024 David Matthew T CFO Sell 91.3 +44,784 1421.71% ✗ $18.1K
Jan 12, 2024 Jan 17, 2024 Mistry Erin Chief Commercial Officer Sell 91.3 +45,611 930.84% ✗ $15.2K
Jan 12, 2024 Jan 17, 2024 Todisco Joseph CEO Sell 91.3 +119,552 54.41% ✗ $47.8K
Dec 14, 2023 Dec 18, 2023 DUNTON ALAN W Director Buy 91.3 +6,000 64.86% ✗ $20.3K
Dec 12, 2023 Dec 14, 2023 Zelnick Kaufman Beth Chief Legal Officer Neutral 90.0 +50,000 100.00% ✗ -
Dec 14, 2023 Zelnick Kaufman Beth Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Nov 17, 2023 Nov 21, 2023 Mistry Erin Chief Commercial Officer Buy 90.0 +1,000 25.64% ✗ $4K
Nov 16, 2023 Nov 17, 2023 Lefkowitz Steven W Director Neutral 52.5 - 0.00% ✗ -
Sep 8, 2023 Sep 8, 2023 Todisco Joseph CEO Buy 83.8 +10,000 4.77% ✗ $37.1K
May 18, 2023 May 19, 2023 Kaplan Myron Director Buy 83.8 +6,000 3.16% ✗ $27.3K
May 17, 2023 May 18, 2023 Costa Paulo F Director Buy 91.3 +10,000 100.00% ✗ $46.5K
May 17, 2023 May 18, 2023 DUNTON ALAN W Director Buy 91.3 +3,000 48.00% ✗ $13K
May 17, 2023 May 18, 2023 Stewart Robert A Director Buy 91.3 +10,000 1000.00% ✗ $43.7K
May 17, 2023 May 18, 2023 Todisco Joseph CEO Buy 78.8 +5,000 2.44% ✗ $22.9K
May 17, 2023 May 17, 2023 Costa Paulo F Director Neutral 90.0 +10,000 100.00% ✗ -
May 17, 2023 May 17, 2023 DUNTON ALAN W Director Neutral 90.0 +3,000 48.00% ✗ -
May 17, 2023 May 17, 2023 Stewart Robert A Director Neutral 90.0 +10,000 1000.00% ✗ -
May 17, 2023 May 17, 2023 Todisco Joseph CEO Neutral 77.5 +5,000 2.44% ✗ -
May 10, 2023 May 12, 2023 Todisco Joseph CEO Sell 22.5 -37,443 -15.46% ✗ $198.4K
Apr 13, 2023 Apr 17, 2023 Stewart Robert A Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2023 Stewart Robert A Director Neutral 52.5 - 0.00% ✗ -
Jan 14, 2023 Jan 20, 2023 Mistry Erin Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 20, 2023 Mistry Erin Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 14, 2023 Jan 18, 2023 Todisco Joseph CEO Neutral 52.5 - 0.00% ✗ -
Jan 14, 2023 Jan 18, 2023 Mounts Phoebe General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 14, 2023 Jan 18, 2023 Lefkowitz Steven W Director Neutral 52.5 - 0.00% ✗ -
Jan 14, 2023 Jan 18, 2023 Dillione Janet Director Neutral 52.5 - 0.00% ✗ -
Jan 14, 2023 Jan 18, 2023 Kaplan Myron Director Neutral 52.5 - 0.00% ✗ -